Skip to main content
Clinical Trials/NCT03921372
NCT03921372
Completed
Not Applicable

Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Patients With Normal Tension Glaucoma

Augenabteilung Allgemeines Krankenhaus Linz1 site in 1 country24 target enrollmentJuly 26, 2018
ConditionsMean Blur Ratio

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mean Blur Ratio
Sponsor
Augenabteilung Allgemeines Krankenhaus Linz
Enrollment
24
Locations
1
Primary Endpoint
Change in mean blur rate
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Glaucoma is the second leading cause of blindness worldwide. Literature shows increasing evidence that dysfunction of ocular microcirculation in the optic nerve influences the progression of glaucoma. It has been shown that flicker light-induced vasodilatation of retinal veins is diminished in patients with glaucoma. Also previous studies indicate that the blood flow autoregulation is impaired in patients with glaucoma. Therefor the ocular perfusion pressure can not be maintained stable during changes of the systemic arterial blood pressure. Laser speckle flowgraphy (LSFG) represents a non-invasive method to quantify ocular perfusion also at the ONH. LSFG enables noninvasive quantification of microcirculation of the optic disc in Japanese glaucoma patients.

Study Objectives:

To assess the changes in LSFG parameters in patients with normal tension glaucoma, compared to healthy subjects during flicker light stimulation and isometric exercises.

Registry
clinicaltrials.gov
Start Date
July 26, 2018
End Date
February 25, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Augenabteilung Allgemeines Krankenhaus Linz
Responsible Party
Principal Investigator
Principal Investigator

Matthias Bolz

Prof.

Augenabteilung Allgemeines Krankenhaus Linz

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • a) Study population: patients with normal tension glaucoma
  • History of ocular or systemic disease causing optic nerve damage
  • History of IOP greater than 21 mm Hg (corrected by CCT)
  • Participation in a clinical trial in the 3 weeks preceding the study
  • Ocular surgery (including intravitreal injection) during the 3 months preceding the study
  • Ametropia \> 6 Dpt
  • pre- or perimenopausal women
  • Relevant ophthalmic diseases/conditions that could interfere with LSFG measurements (e.g. optic nerve head drusen, tilted disc, etc.)
  • Opacities of the cornea (e.g. corneal scars, corneal oedema), the lens (e.g. LOCS-II grading \> 2, posterior capsule opacification) or the vitreous (e.g. vitreous haemorrhage, asteroid hyalosis)
  • Patients who are not able to cooperate or with insufficient ability to fixate (tremor, nystagmus)

Outcomes

Primary Outcomes

Change in mean blur rate

Time Frame: 5 minutes

Study Sites (1)

Loading locations...

Similar Trials